About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | REMISE Study: REMnant Biospecimen Investigation in SEpsis

REMISE Study: REMnant Biospecimen Investigation in SEpsis

NCT05684133·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Pittsburgh

With

Vanderbilt University
National Institute of General Medical Sciences (NIGMS)

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adult patient, at least 18 years of age
Meeting Sepsis-3 criteria within 6 hours of admission
Biospecimens obtained for routine clinical care and measurement
Peripheral intravenous access

You may not be if

Patients who do not have Sepsis-3
Traumatic injury,
Inability to consent or contact legal representative,
Cardiac arrest,
Stroke,
Comfort measures only,
Unable to obtain intravenous access, and/or
Subject declines to participate.
No residual blood left in clinical sample

The record

StatusCompleted

PhaseNo phase

Taking part71

StartedOct 2022

UpdatedFeb 28, 2024

Conditions

Where1

University of Pittsburgh
Pittsburgh, Pennsylvania, United States